NCT04710277

Brief Summary

The study is a randomized controlled trial investigating a multimodal postoperative pain management protocol which will include use of ice therapy and scheduled opioid-sparing medications for pain control after minimally invasive gynecologic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable postoperative-pain

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2020

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 14, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

April 19, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2022

Completed
Last Updated

May 12, 2023

Status Verified

May 1, 2023

Enrollment Period

1.4 years

First QC Date

December 29, 2020

Last Update Submit

May 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Day 1 pain score assessed by NRS-11

    Postoperative day 1 or Day 1 pain score will be measured using a commonly used and validated 11-point numerical rating scale (NRS-11) for pain intensity the morning after surgery between 0600 to 0900. The patient will be prompted to evaluate their current pain at rest. A score of zero will correspond with "no pain" and a score of 10 corresponds with "worst possible pain." The outcome will be recorded directly into their Day 1 study survey in REDCap.

    During the intervention on postoperative day 1 between 0600 to 0900

Secondary Outcomes (14)

  • Day 2 to 4 pain score assessed by NRS-11

    During the intervention on postoperative day 2 to 4

  • Quality of Recovery assessed by QoR-40

    During the intervention on postoperative day 1 and 4

  • Patient satisfaction with pain control assessed by NRS-11

    During the intervention on postoperative day 1 and 4

  • Patient satisfaction with ice therapy assessed by NRS-11

    During the intervention on postoperative day 1 and 4

  • Patient satisfaction with ice therapy assessed by brief questionnaire

    During the intervention on postoperative day 1 and 4

  • +9 more secondary outcomes

Study Arms (2)

Novel multimodal protocol group

EXPERIMENTAL

They will receive scheduled topical ice therapy for 24 hours after surgery. It will be applied over abdominal incisions for 20 minutes every 2-3 hours. Acetaminophen and an NSAID will be scheduled for 96 hours. While inpatient, they will receive acetaminophen 975 mg every 8 hours and IV Toradol 15-30 mg every 6 hours with change to ibuprofen 800 mg every 8 hours when tolerating oral intake. They may take oxycodone 5 mg every 4-6 hours as needed (PRN) for breakthrough pain and pain score \>6. They may use ice PRN after 24 hours. They will be prescribed acetaminophen 1000 mg every 8 hours and ibuprofen 800 mg every 8 hours for 96 hours postoperative. They may take them as needed after. If the participant used 0 narcotics in the first 24 hours, they will not be prescribed a narcotic. If up to 5 tablets were used, they will be prescribed 5 tablets of oxycodone 5 mg every 6 hours PRN. If more than 5 tablets were used, they will be prescribed 10 tablets of oxycodone 5 mg every 6 hours PRN.

Other: Opioid-sparing multimodal pain management

Usual care protocol group

ACTIVE COMPARATOR

Participants randomly assigned to the usual care protocol will receive current standard of care: scheduled acetaminophen and an NSAID for 24 hours. They will take acetaminophen 975 mg every 8 hours. They will also receive IV toradol 15 to 30 mg every 6 hours then switch to ibuprofen 800 mg every 8 hours when tolerating oral intake. They can also take oxycodone 5 mg every 4 to 6 hours on an as needed (PRN) basis for breakthrough pain with a pain score \>6. Per our current standard of care, usual care participants will be allowed to use either topical heat or ice on an as needed basis during their recovery. On discharge home, they will be prescribed acetaminophen 1000 mg every 8 hours PRN and ibuprofen 800 mg every 8 hours PRN. They will also be prescribed 15 tablets of oxycodone 5 mg every 6 hours PRN.

Other: Usual care

Interventions

Ice pack applied to abdominal incisions for 20 minutes every 2 to 3 hours for 24 hours after surgery and scheduled acetaminophen and NSAID for 96 hours after surgery. Narcotic pain medication for severe breakthrough pain.

Also known as: Ice therapy, Ice pack, Cryotherapy
Novel multimodal protocol group

Scheduled acetaminophen and NSAID for 24 hours after surgery. Narcotic pain medication for severe breakthrough pain.

Usual care protocol group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Minimally invasive (laparoscopic or robotic) major gynecologic procedures including: pelvic floor procedures (uterosacral ligament suspension, sacrocolpopexy, Burch colposuspension) with or without concomitant hysterectomy, adnexal surgery, or vaginal surgery; total or supracervical hysterectomy with or without concomitant adnexal surgery, vaginal surgery, or other minor gynecologic procedures
  • Patients admitted to the hospital for at least an overnight observation after their surgery
  • English-speaking
  • Surgery being performed by one of the five attending surgeons included in study

You may not qualify if:

  • Pregnancy. If patient is of childbearing potential and not using contraception a urine pregnancy test will be completed as part of standard practice as part of pre-operative labs.
  • Diagnosis of chronic pelvic pain. Documented pelvic pain noted to be of \>6 months duration.
  • Diagnosis or history of chronic opioid use. Defined as use of opioids most days, for more than 3 months.
  • Diagnosis or history of opioid abuse disorder.
  • Current daily opioid use.
  • Liver, renal, or cardiac disease that is/are a contraindication to any medications used in the study.
  • Allergy or intolerance to any medication used in the study (with exception of oxycodone which can be substituted for hydromorphone if necessary).
  • Dementia or inability to understand or respond to the study measurement tools.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

IceCryotherapy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

WaterHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen CompoundsEnvironmentEcological and Environmental PhenomenaBiological PhenomenaWeatherMeteorological ConceptsEnvironment and Public HealthTherapeutics

Study Officials

  • Silpa Nekkanti, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned prospectively to one of two interventions according to protocol to evaluate the effect of the intervention on their postoperative pain, quality of recovery, patient satisfaction, and overall analgesic use.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 29, 2020

First Posted

January 14, 2021

Study Start

April 19, 2021

Primary Completion

September 20, 2022

Study Completion

October 20, 2022

Last Updated

May 12, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations